Amyloid β cytotoxicity is enhanced or reduced depending on formation of amyloid β oligomeric forms

Objectives We explored the underlying mechanisms that facilitate reducing and enhancing effects of exogenous proteins on cytotoxicity of amyloid β (Aβ), a main pathogen of Alzheimer’s disease, by using an Escherichia coli chaperonin DnaK. Results DnaK was chosen as a tool, because it, easily availab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biotechnology letters 2021, Vol.43 (1), p.165-175
Hauptverfasser: Shahnawaz, Md, Bilkis, Tahmina, Park, Il-Seon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 175
container_issue 1
container_start_page 165
container_title Biotechnology letters
container_volume 43
creator Shahnawaz, Md
Bilkis, Tahmina
Park, Il-Seon
description Objectives We explored the underlying mechanisms that facilitate reducing and enhancing effects of exogenous proteins on cytotoxicity of amyloid β (Aβ), a main pathogen of Alzheimer’s disease, by using an Escherichia coli chaperonin DnaK. Results DnaK was chosen as a tool, because it, easily available and functionally stable, reduced or enhanced Aβ cytotoxicity depending on its concentration. Cytotoxicity was enhanced when the molar ratio of DnaK to Aβ42, at 20 μM Aβ42, was 0.01–0.5, while reduced cytotoxicity was observed at higher ratios (> 1) at 1 μM Aβ42. Significant amounts of oligomeric Aβ42 species accumulated concomitantly with enhanced cytotoxicity, whereas the oligomers appeared to form complexes with DnaK in conditions of reduced cytotoxicity. Conclusions The difference in cytotoxicity was due to variations in the toxic oligomeric Aβ species and DnaK is a useful tool for the study of the Aβ ultrastructure formation and toxicity of Aβ peptide.
doi_str_mv 10.1007/s10529-020-03015-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2476372387</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2476372387</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-d0d7ef670c96ea517a6e19c77cd48ebe2e3fdf45c5c77862858dec6b9dcf83483</originalsourceid><addsrcrecordid>eNp9kEtOwzAQQC0EoqVwARbIEuvA2I7jZFlV_CQkNrC2UntSXDVxsVOJXIuDcCbSptAdK4_s5zfSI-SSwQ0DULeRgeRFAhwSEMBkkh-RMZNKJJlS2TEZA0tZItOCj8hZjEsAKBSoUzISArgUQoyJndbdyjtLv7-o6Vrf-k9nXNtRFyk272Vj0FIfaEC72Y4W19hY1yyob2jlQ122rp98RcuDyK_cwtcYnNkh8ZycVOUq4sX-nJC3-7vX2WPy_PLwNJs-J0Yo2SYWrMIqU2CKDEvJVJkhK4xSxqY5zpGjqGyVSiP7uzzjucwtmmxeWFPlIs3FhFwP3nXwHxuMrV76TWj6lZqnKhOKi1z1FB8oE3yMASu9Dq4uQ6cZ6G1YPYTVfVi9C6u36qu9ejOv0f59-S3ZA2IAYv_ULDAcdv-j_QEau4Zf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2476372387</pqid></control><display><type>article</type><title>Amyloid β cytotoxicity is enhanced or reduced depending on formation of amyloid β oligomeric forms</title><source>SpringerLink Journals</source><creator>Shahnawaz, Md ; Bilkis, Tahmina ; Park, Il-Seon</creator><creatorcontrib>Shahnawaz, Md ; Bilkis, Tahmina ; Park, Il-Seon</creatorcontrib><description>Objectives We explored the underlying mechanisms that facilitate reducing and enhancing effects of exogenous proteins on cytotoxicity of amyloid β (Aβ), a main pathogen of Alzheimer’s disease, by using an Escherichia coli chaperonin DnaK. Results DnaK was chosen as a tool, because it, easily available and functionally stable, reduced or enhanced Aβ cytotoxicity depending on its concentration. Cytotoxicity was enhanced when the molar ratio of DnaK to Aβ42, at 20 μM Aβ42, was 0.01–0.5, while reduced cytotoxicity was observed at higher ratios (&gt; 1) at 1 μM Aβ42. Significant amounts of oligomeric Aβ42 species accumulated concomitantly with enhanced cytotoxicity, whereas the oligomers appeared to form complexes with DnaK in conditions of reduced cytotoxicity. Conclusions The difference in cytotoxicity was due to variations in the toxic oligomeric Aβ species and DnaK is a useful tool for the study of the Aβ ultrastructure formation and toxicity of Aβ peptide.</description><identifier>ISSN: 0141-5492</identifier><identifier>EISSN: 1573-6776</identifier><identifier>DOI: 10.1007/s10529-020-03015-8</identifier><identifier>PMID: 33025333</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Alzheimer's disease ; Amyloid ; Applied Microbiology ; Biochemistry ; Biomedical and Life Sciences ; Biotechnology ; Cytotoxicity ; DnaK protein ; E coli ; Life Sciences ; Microbiology ; Neurodegenerative diseases ; Oligomers ; Original Research Paper ; Toxicity ; Ultrastructure</subject><ispartof>Biotechnology letters, 2021, Vol.43 (1), p.165-175</ispartof><rights>Springer Nature B.V. 2020</rights><rights>Springer Nature B.V. 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-d0d7ef670c96ea517a6e19c77cd48ebe2e3fdf45c5c77862858dec6b9dcf83483</citedby><cites>FETCH-LOGICAL-c375t-d0d7ef670c96ea517a6e19c77cd48ebe2e3fdf45c5c77862858dec6b9dcf83483</cites><orcidid>0000-0003-4754-6142</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10529-020-03015-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10529-020-03015-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33025333$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shahnawaz, Md</creatorcontrib><creatorcontrib>Bilkis, Tahmina</creatorcontrib><creatorcontrib>Park, Il-Seon</creatorcontrib><title>Amyloid β cytotoxicity is enhanced or reduced depending on formation of amyloid β oligomeric forms</title><title>Biotechnology letters</title><addtitle>Biotechnol Lett</addtitle><addtitle>Biotechnol Lett</addtitle><description>Objectives We explored the underlying mechanisms that facilitate reducing and enhancing effects of exogenous proteins on cytotoxicity of amyloid β (Aβ), a main pathogen of Alzheimer’s disease, by using an Escherichia coli chaperonin DnaK. Results DnaK was chosen as a tool, because it, easily available and functionally stable, reduced or enhanced Aβ cytotoxicity depending on its concentration. Cytotoxicity was enhanced when the molar ratio of DnaK to Aβ42, at 20 μM Aβ42, was 0.01–0.5, while reduced cytotoxicity was observed at higher ratios (&gt; 1) at 1 μM Aβ42. Significant amounts of oligomeric Aβ42 species accumulated concomitantly with enhanced cytotoxicity, whereas the oligomers appeared to form complexes with DnaK in conditions of reduced cytotoxicity. Conclusions The difference in cytotoxicity was due to variations in the toxic oligomeric Aβ species and DnaK is a useful tool for the study of the Aβ ultrastructure formation and toxicity of Aβ peptide.</description><subject>Alzheimer's disease</subject><subject>Amyloid</subject><subject>Applied Microbiology</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnology</subject><subject>Cytotoxicity</subject><subject>DnaK protein</subject><subject>E coli</subject><subject>Life Sciences</subject><subject>Microbiology</subject><subject>Neurodegenerative diseases</subject><subject>Oligomers</subject><subject>Original Research Paper</subject><subject>Toxicity</subject><subject>Ultrastructure</subject><issn>0141-5492</issn><issn>1573-6776</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kEtOwzAQQC0EoqVwARbIEuvA2I7jZFlV_CQkNrC2UntSXDVxsVOJXIuDcCbSptAdK4_s5zfSI-SSwQ0DULeRgeRFAhwSEMBkkh-RMZNKJJlS2TEZA0tZItOCj8hZjEsAKBSoUzISArgUQoyJndbdyjtLv7-o6Vrf-k9nXNtRFyk272Vj0FIfaEC72Y4W19hY1yyob2jlQ122rp98RcuDyK_cwtcYnNkh8ZycVOUq4sX-nJC3-7vX2WPy_PLwNJs-J0Yo2SYWrMIqU2CKDEvJVJkhK4xSxqY5zpGjqGyVSiP7uzzjucwtmmxeWFPlIs3FhFwP3nXwHxuMrV76TWj6lZqnKhOKi1z1FB8oE3yMASu9Dq4uQ6cZ6G1YPYTVfVi9C6u36qu9ejOv0f59-S3ZA2IAYv_ULDAcdv-j_QEau4Zf</recordid><startdate>2021</startdate><enddate>2021</enddate><creator>Shahnawaz, Md</creator><creator>Bilkis, Tahmina</creator><creator>Park, Il-Seon</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QR</scope><scope>7T7</scope><scope>7TB</scope><scope>7U5</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>L7M</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0003-4754-6142</orcidid></search><sort><creationdate>2021</creationdate><title>Amyloid β cytotoxicity is enhanced or reduced depending on formation of amyloid β oligomeric forms</title><author>Shahnawaz, Md ; Bilkis, Tahmina ; Park, Il-Seon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-d0d7ef670c96ea517a6e19c77cd48ebe2e3fdf45c5c77862858dec6b9dcf83483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alzheimer's disease</topic><topic>Amyloid</topic><topic>Applied Microbiology</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnology</topic><topic>Cytotoxicity</topic><topic>DnaK protein</topic><topic>E coli</topic><topic>Life Sciences</topic><topic>Microbiology</topic><topic>Neurodegenerative diseases</topic><topic>Oligomers</topic><topic>Original Research Paper</topic><topic>Toxicity</topic><topic>Ultrastructure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shahnawaz, Md</creatorcontrib><creatorcontrib>Bilkis, Tahmina</creatorcontrib><creatorcontrib>Park, Il-Seon</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>ProQuest Central Basic</collection><jtitle>Biotechnology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shahnawaz, Md</au><au>Bilkis, Tahmina</au><au>Park, Il-Seon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amyloid β cytotoxicity is enhanced or reduced depending on formation of amyloid β oligomeric forms</atitle><jtitle>Biotechnology letters</jtitle><stitle>Biotechnol Lett</stitle><addtitle>Biotechnol Lett</addtitle><date>2021</date><risdate>2021</risdate><volume>43</volume><issue>1</issue><spage>165</spage><epage>175</epage><pages>165-175</pages><issn>0141-5492</issn><eissn>1573-6776</eissn><abstract>Objectives We explored the underlying mechanisms that facilitate reducing and enhancing effects of exogenous proteins on cytotoxicity of amyloid β (Aβ), a main pathogen of Alzheimer’s disease, by using an Escherichia coli chaperonin DnaK. Results DnaK was chosen as a tool, because it, easily available and functionally stable, reduced or enhanced Aβ cytotoxicity depending on its concentration. Cytotoxicity was enhanced when the molar ratio of DnaK to Aβ42, at 20 μM Aβ42, was 0.01–0.5, while reduced cytotoxicity was observed at higher ratios (&gt; 1) at 1 μM Aβ42. Significant amounts of oligomeric Aβ42 species accumulated concomitantly with enhanced cytotoxicity, whereas the oligomers appeared to form complexes with DnaK in conditions of reduced cytotoxicity. Conclusions The difference in cytotoxicity was due to variations in the toxic oligomeric Aβ species and DnaK is a useful tool for the study of the Aβ ultrastructure formation and toxicity of Aβ peptide.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>33025333</pmid><doi>10.1007/s10529-020-03015-8</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-4754-6142</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0141-5492
ispartof Biotechnology letters, 2021, Vol.43 (1), p.165-175
issn 0141-5492
1573-6776
language eng
recordid cdi_proquest_journals_2476372387
source SpringerLink Journals
subjects Alzheimer's disease
Amyloid
Applied Microbiology
Biochemistry
Biomedical and Life Sciences
Biotechnology
Cytotoxicity
DnaK protein
E coli
Life Sciences
Microbiology
Neurodegenerative diseases
Oligomers
Original Research Paper
Toxicity
Ultrastructure
title Amyloid β cytotoxicity is enhanced or reduced depending on formation of amyloid β oligomeric forms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A34%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amyloid%20%CE%B2%20cytotoxicity%20is%20enhanced%20or%20reduced%20depending%20on%20formation%20of%20amyloid%20%CE%B2%20oligomeric%20forms&rft.jtitle=Biotechnology%20letters&rft.au=Shahnawaz,%20Md&rft.date=2021&rft.volume=43&rft.issue=1&rft.spage=165&rft.epage=175&rft.pages=165-175&rft.issn=0141-5492&rft.eissn=1573-6776&rft_id=info:doi/10.1007/s10529-020-03015-8&rft_dat=%3Cproquest_cross%3E2476372387%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2476372387&rft_id=info:pmid/33025333&rfr_iscdi=true